TARANTINI, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 36.449
AS - Asia 19.882
EU - Europa 12.634
AF - Africa 5.704
SA - Sud America 4.832
OC - Oceania 549
Continente sconosciuto - Info sul continente non disponibili 261
Totale 80.311
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 33.619
SG - Singapore 7.007
CN - Cina 3.206
BR - Brasile 2.950
HK - Hong Kong 2.576
IT - Italia 2.084
VN - Vietnam 1.464
DE - Germania 1.034
FI - Finlandia 1.021
PL - Polonia 806
SE - Svezia 754
GB - Regno Unito 578
FR - Francia 563
RU - Federazione Russa 557
NL - Olanda 470
UA - Ucraina 399
AR - Argentina 390
IN - India 377
KR - Corea 323
TR - Turchia 291
AT - Austria 269
MX - Messico 256
ZA - Sudafrica 254
IQ - Iraq 248
IE - Irlanda 246
EC - Ecuador 244
ID - Indonesia 225
JP - Giappone 215
AO - Angola 208
CO - Colombia 206
ES - Italia 206
CI - Costa d'Avorio 203
MA - Marocco 191
BJ - Benin 173
GR - Grecia 173
JM - Giamaica 172
PK - Pakistan 172
AL - Albania 171
PY - Paraguay 170
MD - Moldavia 169
SA - Arabia Saudita 167
DO - Repubblica Dominicana 165
AE - Emirati Arabi Uniti 164
BE - Belgio 164
EG - Egitto 163
UZ - Uzbekistan 163
VE - Venezuela 163
TN - Tunisia 161
AZ - Azerbaigian 160
KE - Kenya 160
CL - Cile 159
PE - Perù 159
DZ - Algeria 158
CA - Canada 157
CH - Svizzera 156
GT - Guatemala 156
IR - Iran 156
LV - Lettonia 156
MG - Madagascar 156
MK - Macedonia 155
RS - Serbia 154
TH - Thailandia 152
NP - Nepal 151
CM - Camerun 150
CZ - Repubblica Ceca 150
JO - Giordania 150
GN - Guinea 149
SK - Slovacchia (Repubblica Slovacca) 149
TT - Trinidad e Tobago 149
YT - Mayotte 149
HU - Ungheria 147
KZ - Kazakistan 147
AU - Australia 146
PH - Filippine 146
CW - ???statistics.table.value.countryCode.CW??? 145
MY - Malesia 145
NI - Nicaragua 145
RO - Romania 145
UY - Uruguay 145
PT - Portogallo 144
SN - Senegal 144
BY - Bielorussia 143
HN - Honduras 143
BA - Bosnia-Erzegovina 142
BB - Barbados 141
CV - Capo Verde 141
LB - Libano 141
PS - Palestinian Territory 141
SI - Slovenia 141
GH - Ghana 140
IL - Israele 139
CG - Congo 138
IS - Islanda 138
NO - Norvegia 138
PA - Panama 138
SO - Somalia 138
MZ - Mozambico 137
LA - Repubblica Popolare Democratica del Laos 136
ET - Etiopia 135
BZ - Belize 134
Totale 73.584
Salva come PNG Salva come JPEG
Città #
Fairfield 4.651
Singapore 3.780
Ashburn 3.356
Woodbridge 2.522
Chandler 2.512
Hong Kong 2.455
Houston 2.067
Cambridge 1.660
Seattle 1.655
Wilmington 1.557
Ann Arbor 1.471
Beijing 1.053
Santa Clara 1.009
Jacksonville 916
Boardman 898
Princeton 656
San Diego 603
Bytom 575
Medford 477
Ho Chi Minh City 458
Helsinki 436
Los Angeles 404
Roxbury 376
Padova 358
Des Moines 334
Hefei 290
Nanjing 282
Hanoi 269
Munich 260
São Paulo 258
Chicago 228
New York 204
Abidjan 197
Dong Ket 196
Seoul 194
Dublin 186
Buffalo 184
Luanda 171
Milan 167
Vienna 165
Cotonou 156
Baku 151
Conakry 146
Tashkent 145
Amman 139
Dakar 139
London 139
Antananarivo 137
Managua 137
Turku 133
Riga 131
Bridgetown 130
Nairobi 128
Panama City 128
Nassau 125
Andorra la Vella 123
Libreville 122
Ulan Bator 122
Castries 120
Kampala 119
Montevideo 118
Vientiane 117
Accra 116
Dushanbe 116
Nouakchott 114
Rome 114
Bishkek 112
Phnom Penh 112
Bamako 111
Willemstad 111
Dar es Salaam 110
Praia 110
Harare 109
Kigali 109
Maputo 106
Lima 104
Johannesburg 103
Kingston 103
Podgorica 102
Tokyo 102
Addis Ababa 101
Chisinau 101
Reykjavik 101
Kinshasa 99
Niamey 98
Warsaw 98
Minsk 97
Kingstown 96
Ouagadougou 96
Athens 95
Nuremberg 95
Istanbul 94
Djibouti 93
Havana 93
Lusaka 93
Brooklyn 92
San José 92
Gaborone 91
Guatemala City 91
Rio de Janeiro 90
Totale 46.265
Salva come PNG Salva come JPEG
Nome #
2017 ESC/EACTS Guidelines for the management of valvular heart disease 264
Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial 258
Real-World Experience With a Large Bore Vascular Closure Device During TAVI Procedure: Features and Predictors of Access-Site Vascular Complications 216
Anatomical Predictors of Pacemaker Dependency after Transcatheter Aortic Valve Replacement 214
Unravelling the (arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve 212
Acute decompensated heart failure in young woman with lymphoproliferative disorder 209
Apicobasal gradient of left ventricular myocardial edema underlies transient T-wave inversion and QT interval prolongation (Wellens’ ECG pattern) in Tako-Tsubo cardiomyopathy 208
3D-printing model for complex aortic transcatheter valve treatment 204
'Full-plastic jacket' with bioresorbable vascular scaffolds: 5-year optical coherence tomography follow-up 200
Early and mid-term outcomes of 1904 patients undergoing transcatheter balloon-expandable valve implantation in Italy: results from the Italian Transcatheter Balloon-Expandable Valve Implantation Registry (ITER) 195
Diagnostic value and prognostic implications of early cardiac magnetic resonance in survivors of out-of-hospital cardiac arrest 194
Transcatheter aortic valve implantation and bleeding: Focus on Valve Academic Research Consortium-2 classification. 193
Predictors of relapse, death or heart transplantation in myocarditis before the introduction of immunosuppression: negative prognostic impact of female gender, fulminant onset, lower ejection fraction and serum autoantibodies 193
Asymptomatic Severe Aortic Stenosis and Noncardiac Surgery 192
Cardiac arrest due to acute massive aortic root thrombosis after pericardial bioprosthetic aortic valve replacement 191
The rise of new technologies for aortic valve stenosis: A comparison of sutureless and transcatheter aortic valve implantation 189
Right Ventricular Junctional Late Gadolinium Enhancement Correlates With Outcomes in Pulmonary Hypertension 189
Imaging Study of Ventricular Scar in Arrhythmogenic Right Ventricular Cardiomyopathy: Comparison of 3D Standard Electroanatomical Voltage Mapping and Contrast-Enhanced Cardiac Magnetic Resonance. 188
Coronary microvascular dysfunction correlates with the new onset of cardiac allograft vasculopathy in heart transplant patients with normal coronary angiography. 188
Impact of Changes in Left Ventricular Ejection Fraction on Survival After Transapical Aortic Valve Implantation 185
Design and methodologies of the POSTconditioning during coronary angioplasty in acute myocardial infarction (POST-AMI) trial. 183
Postconditioning during coronary angioplasty in acute myocardial infarction: the POST-AMI trial. 183
Intermediate clinical and hemodynamic outcomes after transcatheter aortic valve implantation presented at the fifty-first annual meeting of the society of thoracic surgeons, San Diego, CA, Jan 24-28, 2015 182
Another passenger for the TAVR speeding train 182
Three-dimensional electroanatomical voltage mapping and histologic evaluation of myocardial substrate in right ventricular outflow tract tachycardia. 181
Trans-subclavian versus transapical access for transcatheter aortic valve implantation: A multicenter study 181
Patent foramen ovale closure and migraine time course: Clues for positive interaction 181
Early and Midterm Clinical and Hemodynamic Outcomes of Transcatheter Valve-in-Valve Implantation: Results From a Multicenter Experience 180
Blood oozing: A cause of life-threatening bleeding without overt source after transcatheter aortic valve replacement 180
"in-house" pharmacological management for computed tomography coronary angiography: Heart rate reduction, timing and safety of different drugs used during patient preparation 180
Coronary vasospasm complicated by ventricular fibrillation: arrhythmogenic morphological substrates detected in vivo by cardiac magnetic resonance. 180
Incidence, Predictors, and Outcome of Conduction Disorders After Transcatheter Self-Expandable Aortic Valve Implantation. 179
Does pre-existing aortic regurgitation protect from death in patients who develop paravalvular leak after TAVI? 176
Transcatheter aortic valve implantation in patients with severe left ventricular dysfunction: immediate and mid-term results, a multicenter study. 175
Depressive symptoms, functional measures and long-term outcomes of high-risk ST-elevated myocardial infarction patients treated by primary angioplasty 175
Apico-Basal Gradient Of Left Ventricular Myocardial Edema Underlies Transient T-Wave Inversion And Qt Interval Prolongation (Wellens' Ecg Pattern) In Tako-Tsubo Cardiomyopathy. 175
Impact of type of intervention for aortic valve replacement on heart rate variability 175
Impact of preoperative mitral valve regurgitation on outcomes after transcatheter aortic valve implantation. 174
Safety and effectiveness of a selective strategy for coronary artery revascularization before transcatheter aortic valve implantation. 174
Three-Dimensional Electroanatomical Voltage Mapping and Histologic Evaluation of Myocardial Substrate in Right Ventricular Outflow Tract Tachycardia 173
Acute procedural and six-month clinical outcome in patients treated with a dedicated bifurcation stent for left main stem disease: the TRYTON LM multicentre registry. 173
Development and validation of a distal embolization risk score during primary angioplasty in ST-elevation myocardial infarction 172
Absorb bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in small vessel disease: A propensity matched analysis of COMPARE II, RAI, and MAASSTAD-ABSORB studies 172
Cardiac rehabilitation after transcatheter versus surgical prosthetic valve implantation for aortic stenosis in the elderly. 170
At-admission risk stratification for in-hospital life-threatening ventricular arrhythmias and death in non-ST elevation myocardial infarction patients. 170
A gender based analysis of predictors of all cause death after transcatheter aortic valve implantation. 170
Impact of atrial fibrillation on outcomes of patients treated by transcatheter aortic valve implantation: A systematic review and meta-analysis 170
Cardiac Magnetic Resonance Features of Biopsy-Proven Endomyocardial Diseases. 169
A2-P3 oblique clipping for the treatment of severe mitral regurgitation in the presence of mitral valve cleft and flail 169
Transcatheter aortic valve replacement for bicuspid aortic valve stenosis with first- and new-generation bioprostheses: A systematic review and meta-analysis 168
TAVR with mechanically expandable prostheses: Is balloon aortic valvuloplasty really necessary? 167
Everolimus-Eluting Bioresorbable Vascular Scaffold System in the Treatment of Cardiac Allograft Vasculopathy: the CART (Cardiac Allograft Reparative Therapy) Prospective Multicenter Pilot Study 166
Impact of myocardial staining on In-hospital outcome after primary percutaneous coronary intervention in the Padua Registry on ST-elevation myocardial infarction 166
Atrial fibrillation in patients undergoing transcatheter aortic valve implantation: epidemiology, timing, predictors, and outcome 166
PCI Versus CABG for Multivessel Coronary Disease in Diabetics 165
Coronary Flow Reserve by Transthoracic Echocardiography Predicts Epicardial Intimal Thickening in Cardiac Allograft Vasculopathy 165
Time-dependent detrimental effects of distal embolization on myocardium and microvasculature during primary percutaneous coronary intervention. 165
Gender-related differences of diabetic patients undergoing percutaneous coronary intervention with drug-eluting stents: A real-life multicenter experience. 165
Coronary angiography after transcatheter aortic valve replacement (TAVR) to evaluate the risk of coronary access impairment after tavr-in-tavr 164
Usefulness of Coronary Sinus Reducer Implantation for the Treatment of Chronic Refractory Angina Pectoris 164
Causes and timing of death during long-term follow-up after transcatheter aortic valve replacement. 163
Transcatheter repair of combined ascending aortic pseudoaneurysm and aortic arch aneurysm through a cardiac transapical approach 163
Clinical outcome of patients with de novo coronary bifurcation lesions treated with the Tryton Side Branch Stent. The SAFE-TRY prospective multicenter single arm study. 163
Association between surgical risk and 30-day stroke after transcatheter versus surgical aortic valve replacement: a systematic review and meta-analysis 163
Management of patients treated with oral anticoagulant therapy undergoing percutaneous coronary intervention with stent implantation: the PERSEO Registry 163
First-in-Human of Catheter-Delivered Annuloplasty Ring to Treat Functional Mitral Regurgitation 162
Impact of baseline hemorrhagic risk on the benefit of bivalirudin versus unfractionated heparin in patients treated with coronary angioplasty: a meta-regression analysis of randomized trials. 162
Myocardial abnormalities underlying persistent ST-segment elevation after anterior myocardial infarction 162
“Full-plastic jacket” with everolimus-eluting Absorb bioresorbable vascular scaffolds: Clinical outcomes in the multicenter prospective RAI registry (ClinicalTrials.gov Identifier: NCT02298413) 162
Association Between Common Cardiovascular Risk Factors and Clinical Phenotype in Patients with Hypertrophic Cardiomyopathy From the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis Registry 162
[Impact of COVID-19 pandemic on structural heart interventions in Italy] 161
Low Serum Testosterone as a New Risk Factor for Chronic Rejection in Heart Transplanted Men 161
Unmasking Myocardial Bridge-Related Ischemia by Intracoronary Functional Evaluation 160
Contrast induced acute kidney injury in interventional cardiology: An update and key guidance for clinicians 160
Coronary Protection to Prevent Coronary Obstruction During TAVR: A Multicenter International Registry 160
Nonamyloidotic Light Chain Cardiomyopathy: The Arrhythmogenic Magnetic Resonance Pattern 159
Comparison of balloon-expandable versus self-expandable valves for transcatheter aortic valve implantation in patients with low-gradient severe aortic stenosis and preserved left ventricular ejection fraction 159
Unravelling the (arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve. 158
Impact of diabetes mellitus on early and midterm outcomes after transcatheter aortic valve implantation (from a multicenter registry). 158
Monitoring patients reported outcomes after valve replacement using wearable devices: Insights on feasibility and capability study: Feasibility results 158
Erectile Dysfunction, Penile Atherosclerosis, and Coronary Artery Vasculopathy in Heart Transplant Recipients 157
Prognostic value of endocardial voltage mapping in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. 156
Incidence, management, and prevention of right ventricular perforation by pacemaker and implantable cardioverter defibrillator leads. 156
Early and Midterm Outcome of Propensity-Matched Intermediate-Risk Patients Aged ≥80 Years With Aortic Stenosis Undergoing Surgical or Transcatheter Aortic Valve Replacement (from the Italian Multicenter OBSERVANT Study) 156
RANKL Expression Is Increased in Circulating Mononuclear Cells of Patients with Calcific Aortic Stenosis 156
Predictors, Incidence, and Outcomes of Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation Complicated by Stroke 156
Coronary Flow Velocity Reserve by Contrast-Enhanced Transthoracic Echocardiography Predicts Maximal Epicardial Intimal Thickening in Cardiac Allograft Vasculopathy 155
Relation of aortic valve weight to severity of aortic stenosis. 155
Using wearable devices to monitor physical activity in patients undergoing aortic valve replacement: Protocol for a prospective observational study 155
Drug-eluting stents for the treatment of coronary lesions in cardiac transplant vasculopathy: acute and mid-term clinical and angiographic outcomes 154
Clinical outcomes of overlapping versus non-overlapping everolimus-eluting absorb bioresorbable vascular scaffolds: An analysis from the multicentre prospective RAI registry (ClinicalTrials.gov identifier: NCT02298413) 154
Impact of Pulmonary Hypertension on Outcomes after Transcatheter Tricuspid Valve Edge-to-Edge Repair 154
Impact of multivessel coronary artery disease on early ischemic injury, late clinical outcome, and remodeling in patients with acute myocardial infarction treated by primary coronary angioplasty. 153
Transcatheter repair of combined ascending aortic pseudoaneurysm and aortic arch aneurysm through a cardiac transapical approach 153
[Updated SICI-GISE position paper on institutional and operator requirements for transcatheter aortic valve implantation] 153
Incidence and management of life-threatening arrhythmias in Takotsubo syndrome. 152
Usefulness and Validation of the Survival posT TAVI Score for Survival After Transcatheter Aortic Valve Implantation for Aortic Stenosis. 151
Asymptomatic right ventricular perforation by an implantable cardioverterdefibrillator lead detected by home monitoring system 150
Coronary Flow Velocity Reserve by Contrast-Enhanced Transthoracic Echocardiography Predicts Maximal Epicardial Intimal Thickening in Cardiac Allograft Vasculopathy 150
Typical and atypical Takotsubo syndrome in the same patient. 150
Totale 17.302
Salva come PNG Salva come JPEG
Categoria #
all - tutte 266.156
article - articoli 259.821
book - libri 598
conference - conferenze 0
curatela - curatele 0
other - altro 223
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.553
Totale 529.351
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.842 0 0 0 0 367 352 248 522 724 540 582 507
2021/20227.564 176 819 873 507 321 601 308 813 693 196 598 1.659
2022/20235.366 1.110 535 142 613 772 586 19 331 558 123 256 321
2023/20243.315 146 424 330 252 273 265 254 202 232 133 373 431
2024/202515.260 265 1.047 636 522 1.900 551 666 1.212 1.351 693 2.433 3.984
2025/202632.594 2.686 5.170 9.833 11.441 3.464 0 0 0 0 0 0 0
Totale 81.183